Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
OrbiMed
company
Investments
Number of Investments
Number of Lead Investments
65
26
OrbiMed has made 65 investments. Their most recent investment was on
Dec 7, 2022, when Apogee Therapeutics, Inc raised
| Date | Company Name | Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|---|
| Dec 7, 2022 | Apogee Therapeutics | Series B | — | Biotechnology | — |
| Nov 14, 2022 | MBX Biosciences | Series B | — | Biotechnology | — |
| Oct 11, 2022 | Treeline Biosciences | Series A | — | Biotechnology | — |
| Sep 12, 2022 | Adaptive Biotechnologies | Post-IPO Debt | — | Biotechnology | Yes |
| Jun 30, 2022 | X4 Pharmaceuticals | Post-IPO Equity | — | Biotechnology | — |
| Jun 9, 2022 | DarioHealth | Post-IPO Debt | — | Health Care | Yes |
| May 9, 2022 | Aspen Neuroscience | Series B | — | Biotechnology | — |
| Apr 26, 2022 | Valneva | Post-IPO Debt | — | Biotechnology | Yes |
| Feb 16, 2022 | Star Therapeutics | Series Unknown | — | — | |
| Oct 21, 2021 | ReCode Therapeutics | Series B | — | Biopharma | — |
| May 13, 2021 | Splisense | Series B | — | Biotechnology | — |
| May 11, 2021 | Caris Life Sciences | Private Equity（PE） | — | Biotechnology | — |
| Apr 27, 2021 | Treeline Biosciences | Series A | — | Biotechnology | Yes |
| Mar 31, 2021 | Scribe Therapeutics | Series B | — | Biotechnology | — |
| Mar 19, 2021 | X4 Pharmaceuticals | Post-IPO Equity | — | Biotechnology | — |
| Jan 7, 2021 | Scorpion Therapeutics | Series B | — | Biotechnology | — |
| Jan 5, 2021 | Terns Pharmaceuticals | Series C | — | Biotechnology | — |
| Oct 27, 2020 | Caris Life Sciences | Private Equity（PE） | — | Biotechnology | — |
| Sep 28, 2020 | BioShin | Series A | — | Biotechnology | Yes |
| Jul 27, 2020 | MBX Biosciences | Series A | — | Biotechnology | — |
| May 27, 2020 | AbCellera | Series B | — | Artificial Intelligence | Yes |
| Apr 1, 2020 | Aspen Neuroscience | Series A | — | Biotechnology | Yes |
| Mar 26, 2020 | ReCode Therapeutics | Series A | — | Biopharma | Yes |
| Mar 23, 2020 | AbCellera | Series A | — | Artificial Intelligence | Yes |
| Dec 12, 2019 | Aspen Neuroscience | Seed | — | Biotechnology | — |
| Sep 4, 2019 | Passage Bio | Series B | — | Biotechnology | — |
| Sep 2, 2019 | Adicet Bio | Series B | — | Biopharma | — |
| Aug 9, 2019 | ORIC Pharmaceuticals | Series D | — | Biotechnology | — |
| May 6, 2019 | Athenex | Post-IPO Equity | — | Biotechnology | — |
| Feb 15, 2019 | Passage Bio | Series A | — | Biotechnology | Yes |
| Feb 8, 2019 | Health Catalyst | Debt Financing | — | Analytics | Yes |
| Feb 8, 2019 | Health Catalyst | Series F | — | Analytics | Yes |
| Oct 30, 2018 | Terns Pharmaceuticals | Series B | — | Biotechnology | Yes |
| Feb 21, 2018 | ORIC Pharmaceuticals | Series C | — | Biotechnology | — |
| Feb 6, 2018 | Asian Institute of Medical Sciences | Series Unknown | — | Biotechnology | — |
| May 16, 2017 | Synlogic | Series C | — | Biotechnology | — |
| May 11, 2017 | Guardant Health | Series E | — | Biotechnology | — |
| Apr 26, 2017 | Arsanis | Series D | — | Biotechnology | — |
| Jan 18, 2017 | ViewRay | Post-IPO Equity | — | Biotechnology | — |
| Aug 22, 2016 | ViewRay | Post-IPO Equity | — | Biotechnology | Yes |
| Apr 13, 2016 | Kala Pharmaceuticals | Series C | — | Biotechnology | — |
| Feb 17, 2016 | Synlogic | Series B | — | Biotechnology | Yes |
| Jan 27, 2016 | Adicet Bio | Series A | — | Biopharma | Yes |
| Jan 7, 2016 | Guardant Health | Series D | — | Biotechnology | Yes |
| Dec 2, 2015 | ORIC Pharmaceuticals | Series B | — | Biotechnology | — |
| Nov 12, 2015 | TigerConnect | Series C | — | Collaboration | — |
| Oct 26, 2015 | Netmeds | Series A | — | E-Commerce | Yes |
| Sep 1, 2015 | Intellia Therapeutics | Series B | — | Biotechnology | Yes |
| Jul 24, 2015 | ViewRay | Post-IPO Equity | — | Biotechnology | — |
| Apr 6, 2015 | Natera | Series F | — | Biotechnology | — |
| Oct 13, 2014 | Invitae | Series F | — | Biotechnology | — |
| Mar 6, 2014 | Domain Surgical | Series C | — | Biotechnology | Yes |
| Jan 27, 2014 | TigerConnect | Series B | — | Collaboration | — |
| Dec 17, 2013 | ViewRay | Series Unknown | — | Biotechnology | — |
| Sep 3, 2013 | Arsanis | Series B | — | Biotechnology | — |
| May 21, 2013 | ViewRay | Series Unknown | — | Biotechnology | — |
| May 1, 2013 | Natera | Series E | — | Biotechnology | Yes |
| Aug 28, 2012 | OmniGuide | Series Unknown | — | Health Care | Yes |
| Apr 2, 2012 | Good Start Genetics | Series B | — | Biotechnology | Yes |
| Mar 13, 2012 | ViewRay | Series C | — | Biotechnology | — |
| Sep 2, 2011 | ViewRay | Debt Financing | — | Biotechnology | — |
| Feb 28, 2011 | Arsanis | Series A | — | Biotechnology | Yes |
| Sep 10, 2010 | Good Start Genetics | Series A | — | Biotechnology | Yes |
| Aug 25, 2010 | ViewRay | Series C | — | Biotechnology | — |
| Jan 23, 2008 | ViewRay | Series B | — | Biotechnology | Yes |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
